Signifor
NDC 55292-133, pasireotide, injection, from Recordati Rare Diseases, Inc..
- Product NDC
- 55292-133
- Status
- Listed
- Labeler
- Recordati Rare Diseases, Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA200677
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55292-133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PASIREOTIDE.9 mg/mL
Pharmacologic classes
Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55292-133-60 | 55292013360 | 60 PACKAGE in 1 BOX (55292-133-60) / 6 AMPULE in 1 PACKAGE (55292-133-06) / 1 mL in 1 AMPULE (55292-133-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a09a25fc-a5a3-0c82-e053-2995a90a5d74
Use it
Look up 55292-133 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55292-133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55292-133. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.